Search research articles
Contact Us
Filters
Showing results (821-830 of 1,968) with videos related to
Page
of 197
Sort By:
Problemy Endokrinologii
|
November 1, 1978
[Plasma kinin system indices in diabetes mellitus patients before and after treatment with prodectin]
V G Spesivtseva, V V Men'shikov, N V Beliakov, et al.
Medicine
|
November 3, 2012
Nonalcoholic fatty liver disease in lean individuals in the United States
Zobair M Younossi, Maria Stepanova, Francesco Negro, et al.
Journal of Viral Hepatitis
|
December 17, 2009
Functional pathway analysis of genes associated with response to treatment for chronic hepatitis C
A Birerdinc, A Afendy, M Stepanova, et al.
Dalton Transactions (Cambridge, England : 2003)
|
April 3, 2023
Cleavable crystals, crystal structure, and magnetic properties of the NbFe<sub>1+</sub>Te<sub>3</sub> layered van der Waals telluride
Valeriy Yu Verchenko, Anna V Stepanova, Alexey V Bogach, et al.
Voprosy Pitaniia
|
March 1, 1988
[Effect of the method of vitaminizing bread made from top-grade wheat flour on its thiamine, riboflavin and niacin content]
E N Stepanova, L N Shatniuk, M F Verzhinskaia, et al.
Acta Naturae
|
October 22, 2025
The Impact of the Intracellular Domains of Chimeric Antigenic Receptors on the Properties of CAR T-cells
D V Volkov, V M Stepanova, I A Yaroshevich, et al.
Gastro Hep Advances
|
July 22, 2025
Assessments of Health Utilities in Patients With Metabolic Dysfunction-Associated Steatohepatitis: Cross-Walk Between Disease-Specific Chronic Liver Disease Questionnaire, Short Form SF-6D, and EuroQol EQ-5D Instruments
Zobair M Younossi, Maria Stepanova, Yestle Kim, et al.
Hepatology (Baltimore, Md.)
|
September 9, 2024
Health-related quality of life (HRQL) assessments in a 52-week, double-blind, randomized, placebo-controlled phase III study of resmetirom (MGL-3196) in patients with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis
Zobair M Younossi, Maria Stepanova, Andrei Racila, et al.
Antibiotiki
|
May 1, 1976
[Toxicity and pharmacological properties of carminomycin complex components]
L E Gol'dberg, T P Vertogradova, S T Filippos'iants, et al.
Biochemistry. Biokhimiia
|
November 13, 2001
Comparative characterization of methods for removal of Cu(II) from the active sites of fungal laccases
O V Koroleva, E V Stepanova, V P Gavrilova, et al.
Page
of 197
Search research articles
Search
Showing results (821-830 of 1,968) with videos related to
Sort By:
Page
of 197
Problemy Endokrinologii
|
November 1, 1978
[Plasma kinin system indices in diabetes mellitus patients before and after treatment with prodectin]
V G Spesivtseva, V V Men'shikov, N V Beliakov, et al.
Medicine
|
November 3, 2012
Nonalcoholic fatty liver disease in lean individuals in the United States
Zobair M Younossi, Maria Stepanova, Francesco Negro, et al.
Journal of Viral Hepatitis
|
December 17, 2009
Functional pathway analysis of genes associated with response to treatment for chronic hepatitis C
A Birerdinc, A Afendy, M Stepanova, et al.
Dalton Transactions (Cambridge, England : 2003)
|
April 3, 2023
Cleavable crystals, crystal structure, and magnetic properties of the NbFe<sub>1+</sub>Te<sub>3</sub> layered van der Waals telluride
Valeriy Yu Verchenko, Anna V Stepanova, Alexey V Bogach, et al.
Voprosy Pitaniia
|
March 1, 1988
[Effect of the method of vitaminizing bread made from top-grade wheat flour on its thiamine, riboflavin and niacin content]
E N Stepanova, L N Shatniuk, M F Verzhinskaia, et al.
Acta Naturae
|
October 22, 2025
The Impact of the Intracellular Domains of Chimeric Antigenic Receptors on the Properties of CAR T-cells
D V Volkov, V M Stepanova, I A Yaroshevich, et al.
Gastro Hep Advances
|
July 22, 2025
Assessments of Health Utilities in Patients With Metabolic Dysfunction-Associated Steatohepatitis: Cross-Walk Between Disease-Specific Chronic Liver Disease Questionnaire, Short Form SF-6D, and EuroQol EQ-5D Instruments
Zobair M Younossi, Maria Stepanova, Yestle Kim, et al.
Hepatology (Baltimore, Md.)
|
September 9, 2024
Health-related quality of life (HRQL) assessments in a 52-week, double-blind, randomized, placebo-controlled phase III study of resmetirom (MGL-3196) in patients with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis
Zobair M Younossi, Maria Stepanova, Andrei Racila, et al.
Antibiotiki
|
May 1, 1976
[Toxicity and pharmacological properties of carminomycin complex components]
L E Gol'dberg, T P Vertogradova, S T Filippos'iants, et al.
Biochemistry. Biokhimiia
|
November 13, 2001
Comparative characterization of methods for removal of Cu(II) from the active sites of fungal laccases
O V Koroleva, E V Stepanova, V P Gavrilova, et al.
Page
of 197